Form 8-K · Current report
Teradyne 8-K, filed Oct 28, 2026
- Filed
- CIK
- 0000097210
- Accession no.
- 0001193125-26-434981
Summary
Teradyne reported third-quarter 2026 revenue of $1,306 million, up 70% from $769 million a year earlier, with GAAP diluted EPS of $2.17 and non-GAAP EPS of $2.29, above the high end of its guidance. CEO Greg Smith attributed the results to demand across the AI value chain, and the company guided fourth-quarter revenue to $1,250–$1,350 million.
Key points
- Semiconductor Test revenue was $1,072 million, Product Test $138 million, and Robotics $96 million in the quarter ended September 27, 2026.
- GAAP net income attributable to Teradyne was $342.4 million, or $2.17 per diluted share; non-GAAP net income was $359.9 million, or $2.29 per diluted share.
- Teradyne said it recorded record revenue in Memory and Integrated Systems Test and that Robotics reached its highest third-quarter revenue and achieved profitability.
- Fourth-quarter 2026 guidance is GAAP EPS of $1.88–$2.18 and non-GAAP EPS of $1.95–$2.25.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 9.01Financial Statements and Exhibits
From the filing
Item 2.02 Results of Operations and Financial Condition. On October 27, 2026, Teradyne, Inc. (“Teradyne”) issued a press release regarding its financial results for the third quarter ended September 27, 2026. Teradyne’s press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit Description 99.1 Press Release dated October 27, 2026. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) Exhibit 99.1: EX-99.1 2 ter-ex99_1.htm EX-99.1 Exhibit 99.1 Teradyne Reports Third Quarter 2026 Results •Revenue up 70% and earnings up over 150% from Q3'25, exceeding the high end of our Q3…
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.